Lindsey Bruce, MD
Obstetrics & Gynecology · Vero Beach, FLNPI 1356672877
Payments from drug & device makers
Across 135 payments — averaging $32.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$542
- Mayne Pharma Commercial LLC$513
- Astellas Pharma US Inc$481
- Sumitomo Pharma America, Inc.$374
- Hologic Sales And Service, LLC$366
- AbbVie$287
- plus $2K from 29 others
What the payments were for
- Travel & lodging$3087%
- Food & beverage$3,84888%
- Education$2135%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $542 |
| Mayne Pharma Commercial LLC | 18 | $513 |
| Astellas Pharma US Inc | 13 | $481 |
| Sumitomo Pharma America, Inc. | 13 | $374 |
| Hologic Sales And Service, LLC | 10 | $366 |
| AbbVie(2 entities) | 10 | $287 |
| Axonics, Inc. | 4 | $286 |
| Medtronic | 7 | $223 |
| Pfizer | 7 | $125 |
| Lilly USA, LLC | 7 | $122 |
| Radius Health, Inc. | 5 | $110 |
| Intuitive Surgical | 1 | $87 |
| Boston Scientific | 1 | $77 |
| Bayer | 3 | $75 |
| Exact Sciences | 3 | $75 |
| Baxter Healthcare | 2 | $61 |
| Scilex Pharmaceuticals Inc. | 3 | $60 |
| Novo Nordisk | 3 | $58 |
| Organon | 2 | $46 |
| Valencia Technologies Corporation | 1 | $45 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Millicent US Inc | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Cosette Pharmaceuticals Inc. | 1 | $24 |
| Lupin Inc. | 1 | $23 |
| Amgen | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Myovant Sciences Inc. | 1 | $21 |
| Duchesnay USA Incorporated | 1 | $21 |
| Inari Medical, Inc. | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$252
- ANNOVERA$125
- Veozah$119
- MYFEMBREE$118
- ACESSA PROVU SYSTEM$105
- NEXTSTELLIS$101
How this compares
$4,369 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 19 | $14,462 |
| Estradiol | 115 | $10,635 |
| MyrbetriqMirabegron | 11 | $7,019 |
| VeozahFezolinetant | 13 | $6,745 |
| PremarinEstrogens, Conjugated | 11 | $6,162 |
| Estradiol (Twice Weekly)Estradiol | 26 | $2,395 |
| ProgesteroneProgesterone, Micronized | 23 | $1,078 |
| Clobetasol Propionate | 25 | $374 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $298 |
| Fluconazole | 24 | $137 |
| Ciprofloxacin Hcl | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $374 | $14,46219 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $481 | $13,76424 claims |
| PfizerPremarin | $125 | $6,16211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Vero Beach
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Rafael Garcia-OcasioHialeah$2M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
- Jorge PandoMiami Lakes$1.5M
- Victoria BedellMiami$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.